Reviewed,
UniProtKB/Swiss-Prot Q92597 (NDRG1_HUMAN)
Last modified
February 9, 2010.
Version 98.
History...
Clusters with 100%,
90%,
50% identity |
Documents (5) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Protein NDRG1 Alternative name(s): N-myc downstream-regulated gene 1 protein Differentiation-related gene 1 protein Short name=DRG-1 Reducing agents and tunicamycin-responsive protein Short name=RTP Nickel-specific induction protein Cap43 Rit42 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Complete proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 394 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | May have a growth inhibitory role. Ref.11 |
| Subcellular location | Cytoplasm. Nucleus. Cell membrane. Note: Whereas in prostate epithelium and placental chorion it is located in both the cytoplasm and the nucleus, nuclear staining is not observed in colon epithelium cells. Instead its localization changes from the cytoplasm to the plasma membrane during differentiation of colon carcinoma cell lines in vitro. |
| Tissue specificity | Ubiquitous; expressed most prominently in placental membranes and prostate, kidney, small intestine, and ovary tissues. Reduced expression in adenocarcinomas compared to normal tissues. In colon, prostate and placental membranes, the cells that border the lumen show the highest expression. |
| Induction | By homocysteine, 2-mercaptoethanol, tunicamycin in endothelial cells. Induced approximately 20-fold during in vitro differentiation of the colon carcinoma cell lines HT29-D4 and Caco-2. Induced by nickel compounds in all tested cell lines. The primary signal for its induction is an elevation of free intracellular calcium ion caused by nickel ion exposure. Okadaic acid, a serine/threonine phosphatase inhibitor, induced its expression more rapidly and more efficiently than nickel. |
| Involvement in disease | Defects in NDRG1 are the cause of Charcot-Marie-Tooth disease type 4D (CMT4D) [MIM:601455]; also known as hereditary motor and sensory neuropathy Lom type (HMSNL). CMT4D is a recessive form of Charcot-Marie-Tooth disease, the most common inherited disorder of the peripheral nervous system. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathy and primary peripheral axonal neuropathy. Demyelinating CMT neuropathies are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. By convention, autosomal recessive forms of demyelinating Charcot-Marie-Tooth disease are designated CMT4. Ref.13 |
| Sequence similarities | Belongs to the NDRG family. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cell membrane Cytoplasm Membrane Nucleus |
| Coding sequence diversity | Polymorphism |
| Disease | Charcot-Marie-Tooth disease Neuropathy |
| Domain | Repeat |
| PTM | Phosphoprotein |
| Technical term | Complete proteome Direct protein sequencing |
| Gene Ontology (GO) | |
| Biological process | response to metal ion Ref.3 Traceable author statement. Source: ProtInc |
| Cellular component | cytoplasm Inferred from direct assay. Source: HPA cytoskeletonInferred from direct assay. Source: HPA nucleusInferred from electronic annotation. Source: UniProtKB-SubCell plasma membraneInferred from electronic annotation. Source: UniProtKB-SubCell |
| Molecular function | protein binding Inferred from physical interaction. Source: IntAct |
| Complete GO annotation... | |
Binary interactions
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 394 | 394 | Protein NDRG1 | PRO_0000159573 | |||||
Regions | |||||||||
| Repeat | 339 – 348 | 10 | 1 | ||||||
| Repeat | 349 – 358 | 10 | 2 | ||||||
| Repeat | 359 – 368 | 10 | 3 | ||||||
| Region | 339 – 368 | 30 | 3 X 10 AA tandem repeats of G-T-R-S-R-S-H-T-S-E | ||||||
Amino acid modifications | |||||||||
| Modified residue | 2 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 319 | 1 | Phosphoserine Ref.12 | ||||||
| Modified residue | 326 | 1 | Phosphoserine Ref.14 Ref.17 | ||||||
| Modified residue | 328 | 1 | Phosphothreonine Ref.14 Ref.17 Ref.21 | ||||||
| Modified residue | 330 | 1 | Phosphoserine Ref.12 Ref.14 Ref.17 Ref.21 Ref.15 Ref.19 | ||||||
| Modified residue | 332 | 1 | Phosphoserine Ref.17 Ref.19 | ||||||
| Modified residue | 333 | 1 | Phosphoserine Ref.17 Ref.21 Ref.19 | ||||||
| Modified residue | 335 | 1 | Phosphothreonine Ref.17 Ref.19 | ||||||
| Modified residue | 336 | 1 | Phosphoserine Ref.12 Ref.17 | ||||||
| Modified residue | 346 | 1 | Phosphothreonine By similarity | ||||||
| Modified residue | 362 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 364 | 1 | Phosphoserine Ref.17 Ref.19 | ||||||
| Modified residue | 366 | 1 | Phosphothreonine Ref.16 | ||||||
| Modified residue | 375 | 1 | Phosphothreonine Ref.17 | ||||||
Natural variations | |||||||||
| Natural variant | 67 | 1 | M → V: dbSNP rs2233319. | VAR_050234 | |||||
| Natural variant | 111 | 1 | M → L: dbSNP rs2233328. | VAR_050235 | |||||
Experimental info | |||||||||
| Sequence conflict | 145 | 1 | I → T in CAA63430. Ref.2 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. GRP78/BiP and novel genes." Kokame K., Kato H., Miyata T. J. Biol. Chem. 271:29659-29665(1996) [PubMed: 8939898] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Umbilical vein endothelial cell. |
| [2] | "A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms." van Belzen N., Dinjens W.N.M., Diesveld M.P.G., Groen N.A., van der Made A.C.J., Nozawa Y., Vlietstra R., Trapman J., Bosman F.T. Lab. Invest. 77:85-92(1997) [PubMed: 9251681] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [3] | "Cap43, a novel gene specifically induced by Ni2+ compounds." Zhou D., Salnikow K., Costa M. Cancer Res. 58:2182-2189(1998) [PubMed: 9605764] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. Tissue: Lung. |
| [4] | "Differential expression of the RTP/Drg1/Ndr1 gene product in proliferating and growth arrested cells." Piquemal D., Joulia D., Balaguer P., Basset A., Marti J., Commes T. Biochim. Biophys. Acta 1450:364-373(1999) [PubMed: 10395947] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [5] | "Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201)." Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B. Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. |
| [6] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Brain. |
| [7] | "DNA sequence and analysis of human chromosome 8." Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S., Asakawa T. Lander E.S.Nature 439:331-335(2006) [PubMed: 16421571] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [8] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Kidney. |
| [9] | Angelicheva D., Kalaydjieva L. Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-21. Tissue: Brain. |
| [10] | Lubec G., Chen W.-Q., Sun Y. Submitted (DEC-2008) to UniProtKB Cited for: PROTEIN SEQUENCE OF 4-19; 54-70; 133-148; 199-212; 286-300; 307-322; 328-341 AND 364-388, MASS SPECTROMETRY. Tissue: Fetal brain cortex. |
| [11] | "Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage." Kurdistani S.K., Arizti P., Reimer C.L., Sugrue M.M., Aaronson S.A., Lee S.W. Cancer Res. 58:4439-4444(1998) [PubMed: 9766676] [Abstract] Cited for: FUNCTION. |
| [12] | "Large-scale characterization of HeLa cell nuclear phosphoproteins." Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J., Li J., Cohn M.A., Cantley L.C., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004) [PubMed: 15302935] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-319; SER-330 AND SER-336, MASS SPECTROMETRY. Tissue: Epithelium. |
| [13] | "N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom." Kalaydjieva L., Gresham D., Gooding R., Heather L., Baas F., de Jonge R., Blechschmidt K., Angelicheva D., Chandler D., Worsley P., Rosenthal A., King R.H.M., Thomas P.K. Am. J. Hum. Genet. 67:47-58(2000) [PubMed: 10831399] [Abstract] Cited for: INVOLVEMENT IN CMT4D. |
| [14] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-326; THR-328 AND SER-330, MASS SPECTROMETRY. Tissue: Epithelium. |
| [15] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed: 16964243] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-330, MASS SPECTROMETRY. Tissue: Epithelium. |
| [16] | "Toward a global characterization of the phosphoproteome in prostate cancer cells: identification of phosphoproteins in the LNCaP cell line." Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S. Electrophoresis 28:2027-2034(2007) [PubMed: 17487921] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-366, MASS SPECTROMETRY. |
| [17] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-326; THR-328; SER-330; SER-332; SER-333; THR-335; SER-336; SER-364 AND THR-375, MASS SPECTROMETRY. |
| [18] | Colinge J., Superti-Furga G., Bennett K.L. Submitted (OCT-2008) to UniProtKB Cited for: IDENTIFICATION [LARGE SCALE ANALYSIS], MASS SPECTROMETRY. |
| [19] | "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach." Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S. Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-330; SER-332; SER-333; THR-335 AND SER-364, MASS SPECTROMETRY. |
| [20] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed: 19369195] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-364, MASS SPECTROMETRY. |
| [21] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-328; SER-330 AND SER-333, MASS SPECTROMETRY. Tissue: T-cell. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | D87953 mRNA. Translation: BAA13505.1. X92845 mRNA. Translation: CAA63430.1. AF004162 mRNA. Translation: AAC13419.1. AF186190 Genomic DNA. No translation available. CR456842 mRNA. Translation: CAG33123.1. AK126924 mRNA. Translation: BAG54400.1. AF192304 Genomic DNA. No translation available. BC003175 mRNA. Translation: AAH03175.1. AF230380 mRNA. Translation: AAF71305.1. |
| IPI | IPI00022078. |
| RefSeq | NP_001128714.1. NP_006087.2. |
| UniGene | Hs.372914 Hs.618002 |
3D structure databases | |
| SMR | Q92597. Positions 31-311. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q92597. 63 interactions. |
| STRING | Q92597. |
Protein family/group databases | |
| MEROPS | S33.988. |
PTM databases | |
| PhosphoSite | Q92597. |
Proteomic databases | |
| PRIDE | Q92597. |
Genome annotation databases | |
| Ensembl | ENST00000323851; ENSP00000319977; ENSG00000104419; Homo sapiens. [Genome view] ENST00000414097; ENSP00000404854; ENSG00000104419; Homo sapiens. [Genome view] |
| GeneID | 10397. |
| KEGG | hsa:10397. |
| UCSC | uc003yug.1. human. |
Organism-specific databases | |
| CTD | 10397. |
| GeneCards | GC08M134318. |
| H-InvDB | HIX0019763. |
| HGNC | HGNC:7679. NDRG1. |
| HPA | HPA006881. |
| MIM | 601455. phenotype. 605262. gene. |
| Orphanet | 99950. Charcot-Marie-Tooth disease, type 4D. |
| PharmGKB | PA31482. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | prNOG15489. |
| HOGENOM | HBG445737. |
| HOVERGEN | Q92597. |
| InParanoid | Q92597. |
| OMA | QEFDVQE. |
| OrthoDB | EOG9QNQFK. |
Enzyme and pathway databases | |
| Pathway_Interaction_DB | hif1_tfpathway. HIF-1-alpha transcription factor network. |
Gene expression databases | |
| ArrayExpress | Q92597. |
| Bgee | Q92597. |
| CleanEx | HS_DRG1. HS_NDRG1. |
| Genevestigator | Q92597. |
| GermOnline | ENSG00000104419. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR004142. Ndr. [Graphical view] |
| PANTHER | PTHR11034. Ndr. 1 hit. |
| Pfam | PF03096. Ndr. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other Resources | |
| NextBio | 39394. |
| SOURCE | Search... |
Entry information
| Entry name | NDRG1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q92597 Secondary accession number(s): O15207 Q9UK29 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation project | HPI (Human Proteome Initiative) | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 8 Human chromosome 8: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with


